Bionumerik pharmaceuticals acquired
WebAug 8, 2016 · DALLAS--(BUSINESS WIRE)--Lantern Pharma, Inc. (Dallas, TX, US) and BioNumerik Pharmaceuticals, Inc. of San Antonio, Texas have entered into an … Web51 to 200 Employees. Type: Company - Private. Industry: Biotech & Pharmaceuticals. Revenue: $5 to $25 million (USD) Competitors: Unknown. BioNumerik Pharmaceuticals does biopharmaceutical drug development by the numbers. Using a multi-discipline process of identifying potential cancer drugs, the company has brought two candidates into late ...
Bionumerik pharmaceuticals acquired
Did you know?
WebNov 8, 2012 · BioNumerik Pharmaceuticals raised $10,190,500 / Series Unknown. Discover more funding rounds . Funding Round ... WebAug 9, 2016 · Aug. 09, 2016 02:42PM PST. Pharmaceutical Investing. DALLAS– (EON: Enhanced Online News)–Lantern Pharma, Inc. (Dallas, TX, US) and BioNumerik Pharmaceuticals, Inc. of San Antonio, Texas have ...
WebAug 9, 2024 · LP-300 was in-licensed from BioNumerik Pharma in May 2016 and acquired from them in January 2024. Following acquisition of the license, Lantern planned a … WebNov 18, 2024 · 31% of BioNumerik Pharmaceuticals employees are Asian. 18% of BioNumerik Pharmaceuticals employees are Hispanic or Latino. The average …
WebThe estimated total pay for a BioNumerik Pharmaceuticals is $55,502 per year in the United States area, with an average salary of $51,532 per year. These numbers represent the median, which is the midpoint of the ranges from our proprietary Total Pay Estimate model and based on salaries collected from our users. The estimated additional pay is ... WebAug 27, 2009 · BioNumerik Pharmaceuticals, Inc. ClinicalTrials.gov Identifier: NCT00966914 Other Study ID Numbers: DMS32212R : First Posted: August 27, 2009 Key Record Dates: Last Update Posted: July 13, 2024 Last Verified: July 2024 Additional relevant MeSH terms: Layout table for MeSH terms ...
WebOct 6, 2004 · LINCOLNSHIRE, Ill. (October 7, 2004) – Takeda Pharmaceutical Company Limited (“Takeda”), the Osaka, Japan-based parent company of Takeda …
WebAug 1, 2006 · BioNumerik has two drug candidates in late-stage clinical development: Tavocept(TM) and Karenitecin (BNP1350). Contacts: Takeda Pharmaceutical Company Limited Corporate Communications Dept. (PR/IR) Seizo Masuda [email protected] Tel: +81-6-6204-2060 BioNumerik Pharmaceuticals, Inc. … how are israeli supreme court justices chosenWebJun 14, 2012 · SAN ANTONIO, June 14, 2012 /PRNewswire/ -- BioNumerik Pharmaceuticals, Inc. ("BioNumerik") today announced the appointment of Mr. Steve … how are iss astronauts weightlessWebAcquired Party. BioNumerik Pharmaceuticals, Inc. Granting Status. Granted. Acquired Entities. BioNumerik Pharmaceuticals, Inc. More Resources. HSR Annual Reports; … how many members are in the cabinet in belizeWeb51 to 200 Employees. Type: Company - Private. Industry: Biotech & Pharmaceuticals. Revenue: $5 to $25 million (USD) Competitors: Unknown. BioNumerik … how many members are in the ffaWebAug 8, 2016 · On Aug 8, 2016. Lantern Pharma has entered into an exclusive agreement to evaluate BioNumerik Pharmaceuticals’ Tavocept for human therapeutic indications using Lantern’s 5-M theranostic platform. Tavocept is an investigational new drug candidate from BioNumerik’s portfolio that has shown potential for both oncology and non-oncology ... how many members are in skzWebMar 2, 2001 · The following is an excerpt from a S-1 SEC Filing, filed by BIONUMERIK PHARMACEUTICALS INC on 3/2/2001. Next Section: Previous Section ... was received by the receiving party from a third party who did not acquire it, directly or indirectly, from the disclosing party under any obligation of confidentiality and which the third party is free to ... how are italian addresses formattedWebBioNumerik Pharmaceuticals General Information Description Operator of an oncology pharmaceutical company focused on discovering and developing novel pharmaceutical … how are issue networks formed quizlet